Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Ertel

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|January 8, 2011
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor functionClay E S Comstock, Michael A Augello, Matthew J Schiewer, et al.
BMC Genomics|January 18, 2013
The complex transcriptional landscape of the anucleate human plateletPaul F Bray, Steven E McKenzie, Leonard C Edelstein, et al.
Cancer Research|November 28, 2013
Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraintXiaoming Ju, Mathew C Casimiro, Michael Gormley, et al.
Cell Cycle (Georgetown, Tex.)|April 23, 2011
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-GenomicsUbaldo E Martinez-Outschoorn, Marco Prisco, Adam Ertel, et al.
Cancer Research|December 17, 2013
Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translationKongming Wu, Ke Chen, Chenguang Wang, et al.
Oncogene|February 6, 2019
Cyclin D1 integrates G9a-mediated histone methylationZhiping Li, Xuanmao Jiao, Gabriele Di Sante, et al.
Cancer Research|December 3, 2014
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell linesDaniela Sicoli, Xuanmao Jiao, Xiaoming Ju, et al.
Gastroenterology|June 28, 2011
RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damageA Kathleen McClendon, Jeffry L Dean, Adam Ertel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung CancerChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|January 8, 2011
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor functionClay E S Comstock, Michael A Augello, Matthew J Schiewer, et al.
BMC Genomics|January 18, 2013
The complex transcriptional landscape of the anucleate human plateletPaul F Bray, Steven E McKenzie, Leonard C Edelstein, et al.
Cancer Research|November 28, 2013
Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraintXiaoming Ju, Mathew C Casimiro, Michael Gormley, et al.
Cell Cycle (Georgetown, Tex.)|April 23, 2011
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-GenomicsUbaldo E Martinez-Outschoorn, Marco Prisco, Adam Ertel, et al.
Cancer Research|December 17, 2013
Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translationKongming Wu, Ke Chen, Chenguang Wang, et al.
Oncogene|February 6, 2019
Cyclin D1 integrates G9a-mediated histone methylationZhiping Li, Xuanmao Jiao, Gabriele Di Sante, et al.
Cancer Research|December 3, 2014
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell linesDaniela Sicoli, Xuanmao Jiao, Xiaoming Ju, et al.
Gastroenterology|June 28, 2011
RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damageA Kathleen McClendon, Jeffry L Dean, Adam Ertel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung CancerChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Pageof 9